Protein phosphorylation studies of cerebral spinal fluid for potential biomarker development

Metallomics

Volumn 2, Issue 5, 2010, Pages 334-341

  Kroening, Karolin K ^a   Kuhlmann, Julia ^a   Easter, Renee ^a   Clark, Joseph F ^b   Pyne Geithman, Gail ^b   Caruso, Joseph A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS 31;

ARTICLE; BRAIN VASOSPASM; CAPILLARY LIQUID CHROMATOGRAPHY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; DISEASE MARKER; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NANO LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION ION TRAP MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; STANDARD; SUBARACHNOID HEMORRHAGE;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; HUMANS; MASS SPECTROMETRY; PHOSPHOPROTEINS; PHOSPHORUS ISOTOPES; PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 77952556992     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c004841k     Document Type: Article

References (22)

1. Association, A.H. American Heart Association, Inc. 2009, available from: \http://www.americanheart.org/.
2. G. J. Rinkel J.v.G.a.E.W. Subarachnoid hemorrhage without detectable aneurysm. A review of the causes Stroke 1993 24 1403 1409
3. J. van Gijn R. S. Kerr G. J. E. Rinkel Subarachnoid haemorrhage Lancet 2007 369 9558 306 318
4. J. Ellis et al. A Preliminary Study of Metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS J. Proteome Res. 2008 7 9 3747 3754
5. G. Khurana, Brain aneurysm, 2006, available from: http://www.brain- aneurysm.com/
6. D, H.E.D.M.J.M.M.E., Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Advances in pharmacology, 1994, 28, 221-68
7. E. D. Hall Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage European Journal of Anaesthesiology 1996 13 3 279 289
8. L. Sarah M. A. Smith M. Heidi B. S. Scherch Edward D. Hall, PhD Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury Journal of Neurosurgery 1996 84 229-33
9. J. Ptacek, et al. Global analysis of protein phosphorylation in yeast Nature 2005 438 7068 679 684
10. ̂'CHIP-ITMS for Identification of Phosphoproteins J. Proteome Res. 2008 7 11 4736 4742
11. R. R. Neubig D. P. Siderovski Regulators of G-protein signalling as new central nervous system drug targets Nat. Rev. Drug Discovery 2002 1 3 187 197
12. R. G. Giffard et al. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury J. Exp. Biol. 2004 207 18 3213 3220
13. W. Yang et al. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation - a new target for therapeutic intervention? J. Neurochem. 2008 106 3 989 999
14. K. Satoh et al. A novel membrane protein, encoded by the gene covering KIAA0233, is transcriptionally induced in senile plaque-associated astrocytes Brain Res. 2006 1108 1 19 27
15. L. Ni et al. C. Cystatin Associated With Hemorrhagic and Ischemic Stroke, Is a Strong Predictor of the Risk of Cardiovascular Events and Death in Chinese Stroke 2007 38 12 3287 3288
16. Q. Tian J. Wang Role of Serine/Threonine Protein Phosphatase in Alzheimer's Disease Neurosignals 2002 11 5 262 269
17. I. Skoog et al. A Population-based Study of tau Protein and Ubiquitin in Cerebrospinal Fluid in 85-year-olds: Relation to Severity of Dementia and Cerebral Atrophy but not to the Apolipoprotein E4 Allele Neurodegeneration 1995 4 4 433 442
18. I. B. Levitan Modulation of ion channels by protein phosphorylation and dephosphorylation Annu. Rev. Physiol. 1994 56 193 212
19. L. A. Raymond C. D. Blackstone R. L. Huganir Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity Trends Neurosci. 1993 16 4 147 153
20. R. J. Abbott I. F. Pye S. R. Nahorski CSF and plasma GABA levels in Parkinson's disease J. Neurol., Neurosurg. Psychiatry 1982 45 3 253 256
21. L. Wolfgang Relationship Between GABA Concentrations in Cerebrospinal Fluid and Seizure Excitability J. Neurochem. 1982 38 1 293 295
22. A. L. Mah et al. Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation J. Cell Biol. 2000 151 4 847 862